Persistence clinical studies: can you believe what you see?
- PMID: 23857273
- PMCID: PMC3901829
- DOI: 10.4161/hv.24168
Persistence clinical studies: can you believe what you see?
Abstract
Long-term immunity, evaluated by the persistence of antibody titers, is important to assess duration of protection induced by vaccination. This paper aims at drawing awareness on the risk of misinterpreting persistence results in absence of adjustment for missing or left-censored data. Using simulations, the paper shows that repeated measurement models are an appropriate alternative to control the bias associated to unadjusted persistence results.
Keywords: left-censored data; long-term antibody; missing data; persistence; repeated measurement.
Figures
References
-
- Carpenter JR, Kenward MG. Missing data in clinical trials—a practical guide. Available at: http://www.hta.ac.uk/nihrmethodology/reports/1589.pdf (accessed 23 Aug 2011).
-
- Molenberghs G, Kenward MG. Missing Data in Clinical Studies. Chichester: Wiley; 2010.
-
- CHMP Guideline on Missing Data in Confirmatory Clinical Trials, EMA/CPMP/EWP/1776/99, 2010.
-
- Verbeke G, Molenberghs G. Linear mixed models for longitudinal data. New York: Springer; 2000.
-
- Little RJA, Rubin DB. Statistical Analysis with Missing Data. New York: J. Wiley & Sons; 1987.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical